Clinical Trials in Houston

Showing 5621-5640 of 17,885 trials

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

NCT02592967

The purpose of this study is to determine the recommended Phase 2 dose (RP2D) of JNJ-64041757 a live attenuated double deleted (LADD) Listeria monocytogenes (bacteria in which two virulence genes, which encode molecules that help cause disease, have been removed) when administered intravenously to participants with advanced (Stage IIIb) or metastatic (Stage IV) NSCLC (adenocarcinoma).

Carcinoma, Non-Small-Cell Lung

Janssen Research & Development, LLC18 participantsStarted Dec 2015

Duarte, California, United States • Baltimore, Maryland, United States • Bethesda, Maryland, United States +6 more locations

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

The purpose of this study is to evaluate the safety, pharmacokinetics (study of what the body does to a drug), and pharmacodynamics (study of what a drug does to the body) of JNJ-42756493, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in adult participants with advanced or refractory solid tumors or lymphoma.

Tumor or Lymphoma

Janssen Research & Development, LLC188 participantsStarted Jun 2012

Birmingham, Alabama, United States • Tucson, Arizona, United States • La Jolla, California, United States +34 more locations

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

Find Trials by Condition in Houston

A Study of Acute Respiratory Infections in Global Outpatient Setting

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Intravitreal Injection Site and Perceived Pain

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Juvenile Idiopathic Arthritis (JIA) Registry

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Pulmonary Rehabilitation Before Lung Cancer Resection

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences